Tandem Diabetes EVP adds shares via RSUs, ESPP
Tandem Diabetes Care EVP & COO Jean-Claude Kyrillos reported routine equity compensation activity involving restricted stock units (RSUs), tax withholding, and an employee stock purchase.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Tandem Diabetes Care EVP & COO Jean-Claude Kyrillos reported routine equity compensation activity involving restricted stock units (RSUs), tax withholding, and an employee stock purchase. On May 15, 2026, 4,038 RSUs converted into common stock and 2,139 shares were withheld to cover taxes, with no shares sold. He also acquired 434 shares through the company’s employee stock purchase plan. Following these transactions, he directly holds 27,671 shares of Tandem Diabetes Care common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 4,038 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,038 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 2,139 | $12.82 | $27K |
| Grant/Award | Common Stock | 434 | $10.90 | $5K |
Footnotes (5)
- F1. Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
- F2. The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2025, through May 15, 2026. This transaction is also exempt under Rule 16b-3(c).
- F3. Awarded on May 30, 2025 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- F4. Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- F5. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2026, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Key Figures
Key Terms
Restricted Stock Unit financial
Employee Stock Purchase Plan financial
Rule 16b-3(c) regulatory
Long-Term Incentive Plan financial
tax withholding requirements financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Tandem Diabetes Care (TNDM) report for Jean-Claude Kyrillos?
What RSU activity was disclosed for Tandem Diabetes Care (TNDM) in this Form 4?
What is the role of tax withholding in the Tandem Diabetes Care (TNDM) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.